137 related articles for article (PubMed ID: 23301545)
21. Inhibition of hepatitis C virus infection by NS5A-specific aptamer.
Yu X; Gao Y; Xue B; Wang X; Yang D; Qin Y; Yu R; Liu N; Xu L; Fang X; Zhu H
Antiviral Res; 2014 Jun; 106():116-24. PubMed ID: 24713119
[TBL] [Abstract][Full Text] [Related]
22. The C-terminal hydrophobic domain of hepatitis C virus RNA polymerase NS5B can be replaced with a heterologous domain of poliovirus protein 3A.
Lee H; Liu Y; Mejia E; Paul AV; Wimmer E
J Virol; 2006 Nov; 80(22):11343-54. PubMed ID: 16971430
[TBL] [Abstract][Full Text] [Related]
23. In vitro selection of RNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus: a possible role of GC-rich RNA motifs in NS5B binding.
Kanamori H; Yuhashi K; Uchiyama Y; Kodama T; Ohnishi S
Virology; 2009 May; 388(1):91-102. PubMed ID: 19328515
[TBL] [Abstract][Full Text] [Related]
24. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo.
Lee KJ; Choi J; Ou JH; Lai MM
J Virol; 2004 Apr; 78(7):3797-802. PubMed ID: 15016899
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus RNA: molecular switches mediated by long-range RNA-RNA interactions?
Shetty S; Stefanovic S; Mihailescu MR
Nucleic Acids Res; 2013 Feb; 41(4):2526-40. PubMed ID: 23275555
[TBL] [Abstract][Full Text] [Related]
26. Isolation of RNA aptamers specific for the 3' X tail of HCV.
Fukuda K; Toyokawa Y; Kikuchi K; Konno K; Ishihara R; Fukazawa C; Nishikawa S; Hasegawa T
Nucleic Acids Symp Ser (Oxf); 2008; (52):205-6. PubMed ID: 18776325
[TBL] [Abstract][Full Text] [Related]
27. cis-acting RNA signals in the NS5B C-terminal coding sequence of the hepatitis C virus genome.
Lee H; Shin H; Wimmer E; Paul AV
J Virol; 2004 Oct; 78(20):10865-77. PubMed ID: 15452207
[TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.
Konno K; Fujita S; Iizuka M; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2008; (52):493-4. PubMed ID: 18776469
[TBL] [Abstract][Full Text] [Related]
29. Isolation of RNA aptamers specific for the HCV minus-IRES domain I.
Konno K; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2007; (51):393-4. PubMed ID: 18029752
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of enhancer and critical cis-acting RNA elements in the protein-encoding region of the hepatitis C virus genome.
Chu D; Ren S; Hu S; Wang WG; Subramanian A; Contreras D; Kanagavel V; Chung E; Ko J; Amirtham Jacob Appadorai RS; Sinha S; Jalali Z; Hardy DW; French SW; Arumugaswami V
J Virol; 2013 May; 87(10):5678-96. PubMed ID: 23487449
[TBL] [Abstract][Full Text] [Related]
31. Genomic-Scale Interaction Involving Complementary Sequences in the Hepatitis C Virus 5'UTR Domain IIa and the RNA-Dependent RNA Polymerase Coding Region Promotes Efficient Virus Replication.
Rance E; Tanner JE; Alfieri C
Viruses; 2018 Dec; 11(1):. PubMed ID: 30597844
[TBL] [Abstract][Full Text] [Related]
32. Novel nucleotide and amino acid covariation between the 5'UTR and the NS2/NS3 proteins of hepatitis C virus: bioinformatic and functional analyses.
Sun HY; Ou NY; Wang SW; Liu WC; Cheng TF; Shr SJ; Sun KT; Chang TT; Young KC
PLoS One; 2011; 6(9):e25530. PubMed ID: 21980483
[TBL] [Abstract][Full Text] [Related]
33. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
[TBL] [Abstract][Full Text] [Related]
34. Development of Optimized Inhibitor RNAs Allowing Multisite-Targeting of the HCV Genome.
Romero-López C; Lahlali T; Berzal-Herranz B; Berzal-Herranz A
Molecules; 2017 May; 22(5):. PubMed ID: 28531161
[TBL] [Abstract][Full Text] [Related]
35. Poly(C)-binding protein 2 interacts with sequences required for viral replication in the hepatitis C virus (HCV) 5' untranslated region and directs HCV RNA replication through circularizing the viral genome.
Wang L; Jeng KS; Lai MM
J Virol; 2011 Aug; 85(16):7954-64. PubMed ID: 21632751
[TBL] [Abstract][Full Text] [Related]
36. The conserved lysine 151 of HCV NS5B modulates viral genome replication and infectious virus production.
Haqshenas G
J Viral Hepat; 2012 Dec; 19(12):862-6. PubMed ID: 23121364
[TBL] [Abstract][Full Text] [Related]
37. Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro.
Bellecave P; Andreola ML; Ventura M; Tarrago-Litvak L; Litvak S; Astier-Gin T
Oligonucleotides; 2003; 13(6):455-63. PubMed ID: 15025912
[TBL] [Abstract][Full Text] [Related]
38. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
[TBL] [Abstract][Full Text] [Related]
39. HuR Displaces Polypyrimidine Tract Binding Protein To Facilitate La Binding to the 3' Untranslated Region and Enhances Hepatitis C Virus Replication.
Shwetha S; Kumar A; Mullick R; Vasudevan D; Mukherjee N; Das S
J Virol; 2015 Nov; 89(22):11356-71. PubMed ID: 26339049
[TBL] [Abstract][Full Text] [Related]
40. Conserved RNA secondary structures and long-range interactions in hepatitis C viruses.
Fricke M; Dünnes N; Zayas M; Bartenschlager R; Niepmann M; Marz M
RNA; 2015 Jul; 21(7):1219-32. PubMed ID: 25964384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
